For the fourth quarter of 2011, Retalix Ltd - RTLX - posted total revenues of $62.5 million, a 16.2% increase year over year. GSE Systems Inc - GVP - announced new contracts valued at approximately $8.0 million involving nuclear, fossil, and process simulation, tutorials, and consulting services. Each of these projects was awarded during the first quarter of 2012. iBio Inc - IBIO - reported issuance of a US patent covering the use of iBio’s proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications. ********************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).
投稿者: karmastock
投稿日時:2012-03-01 03:54:33.0
視聴回数:642回
お気に入り登録:0
カテゴリ:
ビジネス全般
タグ:
RTLX
GVP
IBIO
Amex:GVP
Amex:IBIO
Nasdaq:RTLX